Literature DB >> 21490587

The biology of immunoglobulin free light chains and kidney injury.

Kolitha Basnayake1, Stephanie J Stringer, Colin A Hutchison, Paul Cockwell.   

Abstract

Kidney injury caused by immunoglobulin free light chains (FLCs) in the setting of plasma cell dyscrasias is common and associated with increased morbidity and mortality. All compartments of the kidney may be affected, from the glomerulus to the tubulointerstitium, in a wide variety of disease patterns. Here, we review our current knowledge of the biological effects of FLCs and the mechanisms that lead to kidney injury.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21490587     DOI: 10.1038/ki.2011.94

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  27 in total

1.  Association of Serum Ig Free Light Chains with Mortality and ESRD among Patients with Nondialysis-Dependent CKD.

Authors:  James Ritchie; Lakhvir K Assi; Anne Burmeister; Richard Hoefield; Paul Cockwell; Philip A Kalra
Journal:  Clin J Am Soc Nephrol       Date:  2015-03-30       Impact factor: 8.237

2.  Serum free light chains and the risk of ESRD and death in CKD.

Authors:  Richard Haynes; Colin A Hutchison; Jonathan Emberson; Tanaji Dasgupta; David C Wheeler; John N Townend; Martin J Landray; Paul Cockwell
Journal:  Clin J Am Soc Nephrol       Date:  2011-10-27       Impact factor: 8.237

Review 3.  Current Trends of Renal Impairment in Multiple Myeloma.

Authors:  Punit Yadav; Mark Cook; Paul Cockwell
Journal:  Kidney Dis (Basel)       Date:  2016-02-03

4.  The importance of screening for serum free light chains in suspected cases of multiple myeloma and their impact on the kidney.

Authors:  B Talbot; D Wright; K Basnayake
Journal:  BMJ Case Rep       Date:  2014-10-17

Review 5.  Paraprotein-Related Kidney Disease: Kidney Injury from Paraproteins-What Determines the Site of Injury?

Authors:  Mona Doshi; Amit Lahoti; Farhad R Danesh; Vecihi Batuman; Paul W Sanders
Journal:  Clin J Am Soc Nephrol       Date:  2016-08-15       Impact factor: 8.237

6.  Paraprotein-Related Kidney Disease: Diagnosing and Treating Monoclonal Gammopathy of Renal Significance.

Authors:  Mitchell H Rosner; Amaka Edeani; Motoko Yanagita; Ilya G Glezerman; Nelson Leung
Journal:  Clin J Am Soc Nephrol       Date:  2016-08-15       Impact factor: 8.237

Review 7.  Kidney disease and multiple myeloma.

Authors:  Eliot C Heher; Helmut G Rennke; Jacob P Laubach; Paul G Richardson
Journal:  Clin J Am Soc Nephrol       Date:  2013-07-18       Impact factor: 8.237

Review 8.  Kidney injury and disease in patients with haematological malignancies.

Authors:  Frank Bridoux; Paul Cockwell; Ilya Glezerman; Victoria Gutgarts; Jonathan J Hogan; Kenar D Jhaveri; Florent Joly; Samih H Nasr; Deirdre Sawinski; Nelson Leung
Journal:  Nat Rev Nephrol       Date:  2021-03-30       Impact factor: 28.314

9.  Proteomic analysis of urine in medication-overuse headache patients: possible relation with renal damages.

Authors:  Elisa Bellei; Aurora Cuoghi; Emanuela Monari; Stefania Bergamini; Luca Isaia Fantoni; Maurizio Zappaterra; Simona Guerzoni; Annalisa Bazzocchi; Aldo Tomasi; Luigi Alberto Pini
Journal:  J Headache Pain       Date:  2011-10-14       Impact factor: 7.277

10.  Serum and urine free light chains measurements in patients with systemic sclerosis: novel biomarkers for disease activity.

Authors:  Antonietta Gigante; Chiara Pellicano; Giorgia Leodori; Cecilia Napodano; Lorenzo Vantaggio; Francesca Gulli; Mariapaola Marino; Marcella Visentini; Edoardo Rosato; Umberto Basile
Journal:  Clin Exp Immunol       Date:  2021-06-02       Impact factor: 5.732

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.